HOT NEWS
Bayer
The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer RSS Channel

Filter     Display # 
# Article Title Hits
1 Bayer Successful in a Difficult Environment 322
2 Visanne® cleared for market launch in Europe as new treatment option for endometriosis 568
3 Bayer Team wins the "Deutscher Zukunftspreis" awarded by the German President 480
4 Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy 738
5 The risk of venous thromboembolism (VTE) associated with oral hormonal contraceptives 444
6 Bayer Schering Pharma collaborates with AC Immune in the field of Alzheimer's disease 1071
7 Nexavar® Demonstrates 74 Percent Improvement in Progression-Free Survival 850
8 Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF) 1257
9 New Levitra® formulation submitted for registration in the EU 734
10 Bayer HealthCare and Genzyme Finalize Strategic Alliance Agreement 563
11 Qlaira® - innovative estradiol-based oral contraceptive available in Europe 1243
12 Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch 628
13 Overall Consensus of the European Nutritionals Press Workshop 771
14 Bayer Crop Science and the French research organization CNRS intensify collaboration 531
15 Bayer Offers New Betaferon® Titration Pack 739
16 New image of therapy for erectile difficulties 1126
17 The Bayer Group achieved its earnings targets for 2008 750
18 Advances in Renal Cancer Journalists' Award 447
19 Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center 842
20 Bayer Schering Pharma Starts Phase III Program of New Drug Against Pulmonary Hypertension 753
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share

Banner